Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-10-14

Clinical Trial Update: TNF-alpha Inhibition in CRPS: A Randomized Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial investigating TNF-alpha inhibition for Complex Regional Pain Syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: CRPS, Chronic Regional Pain Syndrome | NA | Status: WITHDRAWN